Rather than adopting berberine reflexively or combining medications without guidance, working with a healthcare provider who understands your genetic profile, metabolic markers, and treatment goals ensures your strategy is tailored to your biologynot a one-size-fits-all protocol
Glucagon Inhibition: It reduces the secretion of glucagon, a hormone that raises blood sugar levels, thus preventing excessive glucose production by the liver
concurrent tobacco smoking further augments thrombotic risk, and careful monitoring is advised when estrogens are co-administered with thyroid hormones, corticosteroids, or anticoagulants due to possible alterations in binding protein levels and pharmacodynamic response
Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization
Full publication of combination-therapy data is awaited, however interim analysis from the phase II COURAGE trial (NCT06299098) found 3.3% reduction in lean mass of obese patients treated with the combination of trevogrumab and semaglutide, compared with 6.5% reduction with semaglutide alone [70]